MyoD, or Myoblast Determination Protein, is a master regulatory transcription factor vital for muscle differentiation and the formation of skeletal muscle lineage. It is one of the members of the Myogenic Regulatory Factors (MRFs) family, which plays a significant role in the conversion of undifferentiated mesenchymal cells into myoblasts and eventually into mature muscle fibers. Given the intricate involvement of MyoD in these processes, various chemicals, both natural and synthetic, have been identified that can activate or modulate the function of MyoD. These chemicals are collectively termed MyoD Activators.
These activators operate through diverse mechanisms. For instance, certain chemicals influence the epigenetic landscape surrounding the MyoD gene, thereby altering its transcription. DNA methyltransferase inhibitors, such as 5-Aza-2'-deoxycytidine, activate MyoD by demethylating the CpG islands in its promoter. On the other hand, histone deacetylase inhibitors like Trichostatin A and Valproic Acid promote acetylation of histones, leading to a relaxed chromatin structure and increased MyoD transcription. Other activators might interact with signaling pathways intersecting with MyoD function. For instance, compounds like Forskolin can indirectly boost MyoD expression by elevating cyclic AMP levels and activating protein kinase A. Furthermore, some chemicals, such as MG132, a proteasome inhibitor, increase the stability and activity of MyoD by preventing its degradation. Each MyoD activator offers a unique insight into the intricate molecular mechanisms governing muscle cell differentiation and the complex networks that MyoD interacts with during this process.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor. It can activate MyoD by demethylating the CpG islands in the MyoD promoter, thus increasing MyoD transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor. TSA promotes acetylation of histones, leading to a more open chromatin structure, which in turn can increase the transcriptional activity of MyoD. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Another histone deacetylase inhibitor. Similar to TSA, it can promote MyoD transcription by affecting chromatin structure. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A vitamin A derivative. It can modulate MyoD expression through retinoic acid receptors, which then interact with the MyoD promoter. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
An activator of adenylate cyclase. By increasing cyclic AMP levels, it can activate protein kinase A, leading to enhanced MyoD expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A synthetic glucocorticoid. It can promote MyoD expression and muscle cell differentiation by modulating glucocorticoid response elements and other signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor. While primarily inhibitory, in certain contexts, it can modulate the p38 MAPK pathway in a way that indirectly favors MyoD activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A phosphatidylinositol-3-kinase (PI3K) inhibitor. By blocking the PI3K/Akt pathway, it can counteract inhibitory signals and indirectly increase MyoD activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor. It prevents the degradation of MyoD protein, thereby increasing its stability and activity. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Rocaglamide has been shown to enhance MyoD transcriptional activity, possibly by modulating signaling pathways that intersect with MyoD function. |